Gangolli Julian S is a director of Krystal Biotech Inc.
Person profile
Roles
Address
Irvine, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Outlook Therapeutics, Inc.
8 Mar 24
4
Outlook Therapeutics, Inc.
6 Oct 23
4
Krystal Biotech, Inc.
3 Jul 23
4
Revance Therapeutics, Inc.
5 May 23
4
Outlook Therapeutics, Inc.
31 Mar 23
4
Outlook Therapeutics, Inc.
7 Oct 22
4
Krystal Biotech, Inc.
1 Jul 22
4/A
Revance Therapeutics, Inc.
13 May 22
4
Revance Therapeutics, Inc.
6 May 22
4
Outlook Therapeutics, Inc.
24 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.41 | 94,441 | 38.72 k | 94,441 |
4 Oct 23 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.24 | 370,282 | 88.87 k | 370,282 |
30 Jun 23 | KRYS Krystal Biotech | Stock Option Common Stock | Grant | Acquire A | No | No | 117.4 | 6,800 | 798.32 k | 6,800 |
3 May 23 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 3,534 | 0.00 | 30,106 |
3 May 23 | RVNC Revance Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 33.61 | 5,915 | 198.80 k | 5,915 |
29 Mar 23 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.05 | 41,065 | 43.12 k | 41,065 |